av/panacea-biotec--big.svg

COM:PANACEABIOTEC

Panacea Biotec

  • Stock

Last Close

414.00

22/11 09:59

Market Cap

8.60B

Beta: -

Volume Today

119.87K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
net income
-1.11B
-
-1.07B
4.01%
-189.30M
82.23%
-567.20M
199.63%
-661.39M
16.61%
462.25M
169.89%
-1.77B
483.65%
-1.45B
18.22%
14.49B
1,098.97%
128M
99.12%
-11.70M
109.14%
depreciation and amortization
711M
-
672.30M
5.44%
733.20M
9.06%
677M
7.67%
585.33M
13.54%
550.32M
5.98%
441.35M
19.80%
460.74M
4.39%
436.61M
5.24%
391.20M
10.40%
367.10M
6.16%
deferred income tax
stock based compensation
change in working capital
1.13B
-
-272.80M
124.05%
-582.60M
113.56%
170.10M
129.20%
214.48M
26.09%
1.27B
493.63%
-974.96M
176.57%
219.08M
122.47%
3.02B
1,276.35%
-3.38B
212.07%
102.20M
103.02%
accounts receivables
347.35M
-
201.14M
42.09%
-168.57M
183.81%
-463.40M
174.90%
68.94M
114.88%
29.60M
57.06%
inventory
481.20M
-
352.40M
26.77%
49.90M
85.84%
-6.60M
113.23%
-188.32M
2,753.33%
847.63M
550.10%
-662.64M
178.18%
-264.45M
60.09%
-385.80M
45.89%
106.30M
127.55%
241.60M
127.28%
accounts payables
75.06M
-
-496.89M
761.99%
235.08M
147.31%
other working capital
652.90M
-
-625.20M
195.76%
-632.50M
1.17%
176.70M
127.94%
402.80M
127.96%
3.17M
99.21%
-16.57M
622.71%
417.02M
2,616.72%
3.86B
826.69%
-3.55B
191.98%
-169M
95.25%
other non cash items
-136.30M
-
1.04B
861.48%
945.60M
8.89%
866.70M
8.34%
1.04B
20.20%
-1.24B
218.74%
2.00B
261.87%
1.84B
8.20%
-19.02B
1,134.99%
-1.37B
92.77%
62.50M
104.55%
net cash provided by operating activities
599.20M
-
372.30M
37.87%
906.90M
143.59%
1.15B
26.43%
1.18B
2.93%
1.05B
11.14%
-304.70M
129.05%
1.07B
450.39%
-1.08B
201.57%
-4.23B
290.52%
57.10M
101.35%
investments in property plant and equipment
-559.80M
-
-78.30M
86.01%
-113.20M
44.57%
-328.40M
190.11%
-152.16M
53.67%
-47.83M
68.57%
-69.11M
44.49%
-217.63M
214.90%
-125.10M
42.52%
-409.50M
227.34%
-777.20M
89.79%
acquisitions net
-230.50M
-
723.07M
413.70%
-820K
100.11%
452.21M
55,247.56%
55.90M
87.64%
18.22B
32,493.92%
-4.20B
123.06%
66.80M
101.59%
purchases of investments
-17.80M
-
-332.20M
1,766.29%
-20.70M
93.77%
-9.90M
52.17%
-38.73M
291.21%
-37.74M
2.56%
-452.93M
1,100.13%
-391.93M
13.47%
-10.49B
2,577.42%
-8.68B
17.32%
-3.47B
59.97%
sales maturities of investments
222.80M
-
13.80M
93.81%
22.08M
60%
20.29M
8.11%
720K
96.45%
336.03M
46,570.83%
5.17B
1,439.04%
12.88B
149.01%
4.20B
67.37%
other investing activites
139.70M
-
36.80M
73.66%
75.50M
105.16%
246.70M
226.75%
-1.32M
100.54%
12.58M
1,053.03%
-278.49M
2,313.75%
-259.16M
6.94%
52.80M
120.37%
4.71B
8,825.70%
net cash used for investing activites
-437.90M
-
-373.70M
14.66%
164.40M
143.99%
-308.30M
287.53%
552.94M
279.35%
-53.52M
109.68%
-347.60M
549.48%
-476.79M
37.17%
12.83B
2,790.02%
4.30B
66.45%
18.50M
99.57%
debt repayment
-143.10M
-
-813.40M
468.41%
-1.22B
49.78%
-818.50M
32.82%
-646.43M
21.02%
-347.50M
46.24%
-6.39B
1,739.44%
-489.14M
92.35%
-7.86B
1,507.65%
-147.80M
98.12%
-2.40M
98.38%
common stock issued
1M
-
320M
-
common stock repurchased
dividends paid
other financing activites
-159.50M
-
805.40M
604.95%
44.50M
94.47%
-24M
153.93%
-997.05M
4,054.38%
-663.90M
33.41%
6.98B
1,151.28%
18.04M
99.74%
-3.89B
21,690.35%
-36M
99.08%
net cash used provided by financing activities
-302.60M
-
-7M
97.69%
-1.17B
16,668.57%
-842.50M
28.22%
-1.64B
95.07%
-1.01B
38.46%
907.39M
189.72%
-471.10M
151.92%
-11.76B
2,395.98%
-183.80M
98.44%
-2.40M
98.69%
effect of forex changes on cash
200K
-
100K
-
-3.57M
-
2.43M
168.07%
-1.14M
146.91%
-130K
88.60%
10.10M
7,869.23%
net change in cash
-141.10M
-
-8.40M
94.05%
-102.40M
1,119.05%
-4.20M
95.90%
89.69M
2,235.48%
-19.71M
121.98%
257.52M
1,406.54%
118.61M
53.94%
-17.29M
114.58%
-105M
507.29%
996.28M
1,048.84%
cash at beginning of period
349.50M
-
208.40M
40.37%
199.90M
4.08%
97.30M
51.33%
74.68M
23.25%
164.37M
120.10%
144.66M
11.99%
402.18M
178.02%
520.79M
29.49%
503.50M
3.32%
398.52M
20.85%
cash at end of period
208.40M
-
200M
4.03%
97.50M
51.25%
93.10M
4.51%
164.37M
76.55%
144.66M
11.99%
402.18M
178.02%
520.79M
29.49%
503.50M
3.32%
398.50M
20.85%
1.39B
250.01%
operating cash flow
599.20M
-
372.30M
37.87%
906.90M
143.59%
1.15B
26.43%
1.18B
2.93%
1.05B
11.14%
-304.70M
129.05%
1.07B
450.39%
-1.08B
201.57%
-4.23B
290.52%
57.10M
101.35%
capital expenditure
-559.80M
-
-78.30M
86.01%
-113.20M
44.57%
-328.40M
190.11%
-152.16M
53.67%
-47.83M
68.57%
-69.11M
44.49%
-217.63M
214.90%
-125.10M
42.52%
-409.50M
227.34%
-777.20M
89.79%
free cash flow
39.40M
-
294M
646.19%
793.70M
169.97%
818.20M
3.09%
1.03B
25.65%
1.00B
2.64%
-373.81M
137.35%
850.01M
327.39%
-1.21B
242.29%
-4.64B
283.98%
-720.10M
84.49%

All numbers in (except ratios and percentages)